Dr. Melissa M. Boltz, DO

Dr. Boltz practices at Penn State Health Milton S. Hershey Medical Center in Hershey, Pennsylvania, part of Penn State.

Dr. Boltz's NPI, 1861612095, was assigned on April 30, 2007. Dr. Boltz graduated from Pcom in 2006. Dr. Boltz holds Pennsylvania license OT011793.

Dr. Boltz's primary practice is Penn State Health Milton S. Hershey Medical Center, at 500 University Drive, Hershey, PA 17033 in Dauphin County. The practice phone is (717) 531-8521.

Dr. Boltz's primary practice is Penn State Health Milton S. Hershey Medical Center in Hershey, Pennsylvania, part of Penn State. The medical group on file is Penn State Health Milton S. Hershey Medical Center. Dmand AI also links Dr. Boltz to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Boltz practices. Vendor and product names are available with a free account.

Surgery is Dr. Boltz's primary specialty in the NPI Registry, under taxonomy code 208600000X. Dr. Boltz is board certified in surgery by the American Board of Surgery. Dr. Boltz is licensed in Pennsylvania.

Dmand AI lists chest trauma, collapsed lung, gallbladder removal, gastrointestinal obstruction, multiple traumatic injuries, thyroid surgery and traumatic coma among the conditions Dr. Boltz treats.

CMS data shows 54 Medicare services from Dr. Boltz across 3 procedure codes in 2024, for 84 Medicare patients. Medicare paid $3,344 for them.

CMS counts 84 Medicare patients who saw Dr. Boltz in 2024. The largest group is 65 to 74, with 33 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 1.61, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Boltz's median patient age at 67, with 75% women.

In 2024, Dr. Boltz wrote 17 Medicare Part D claims. 100% of them were for generic drugs. CMS names the drug for 13 of them, across 1 drug with 11 or more claims each, at $49 in total drug cost. In 2023, CMS named 13 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 79 out of 100 for Dr. Boltz for performance year 2024, reported as part of a group. Dr. Boltz accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 24 papers to Dr. Boltz, published from 2011 to 2024. 2011 was the busiest year, with 3. The most frequent topics are Length of Stay, Postoperative Complications and Health Care Costs. Dr. Boltz has published most often in Surgery. Dr. Boltz's most frequent co-authors are Rondi Beth Gelbard, Deborah M. Stein, MD and Michael William Cripps, MD.

Dmand AI links Dr. Boltz to 2 clinical trials, 2 of them phase 3 studies. Conditions studied include Fournier Gangrene, Peritonitis and Fasciitis, Necrotizing. Atox Bio Ltd sponsors the most, 2.

CMS Open Payments shows 21 general payments to Dr. Boltz from 6 drug and device companies from 2020 to 2025. Consulting fees make up the largest share, 75% of the total. Pfizer Inc. paid the most, $21,285.

Dmand AI lists 3 awards for Dr. Boltz, most recently Resident Mentor/Leader Award in 2014.

Dr. Boltz graduated from Pcom in 2006. Dr. Boltz is a member of American Association of Endocrine Surgeons (AAES), ACS and American Head and Neck Society.

Dr. Boltz is in network with 13 carriers, including Aetna, Highmark and Elevance. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.